NovoCure Limited financial statements
NovoCure Limited's income statement, balance sheet and cash flow, annual and quarterly, each figure dated and linked to the filing it was read from.
FY2025
| Revenue | USD 655.35M | 10-Q |
| Net income | −USD 136.23M | 10-Q |
| Cash and equivalents | USD 93.55M | 10-Q |
| Total debt | USD 195.05M | 10-Q |
NovoCure Limited financials on 6ix · NovoCure Limited on 6ix